News & Updates

Photobiomodulation works for chemo-induced peripheral neuropathy

06 Sep 2023 by

Photobiomodulation helps to reduce the severity of chemotherapy-induced peripheral neuropathy (CIPN) and increases mobility in cancer patients as shown in a study presented at EAN 2023.

Photobiomodulation works for chemo-induced peripheral neuropathy

06 Sep 2023

Weight loss with high-dose oral semaglutide in obese nondiabetics

06 Sep 2023 by

A higher dose of oral semaglutide than the currently approved 14 mg/day dose may be the next option for overweight or obese patients wanting to lose pounds.

Weight loss with high-dose oral semaglutide in obese nondiabetics

06 Sep 2023

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

05 Sep 2023

Combination treatment with pembrolizumab and lenvatinib appears to be a better option for patients with recurrent endometrial cancer (REC) or advanced endometrial cancer (AEC) with a platinum-free interval (PFI) of <6 months, suggests a recent study.

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

05 Sep 2023

New COVID-19 variant puts scientists on alert

05 Sep 2023 by

COVID-19 testing has picked up a new coronavirus variant called BA.2.86 – nicknamed Pirola, after an asteroid – in several countries.

New COVID-19 variant puts scientists on alert

05 Sep 2023

Atopic dermatitis linked to subsequent IBD

05 Sep 2023

Children and adults with atopic dermatitis (AD) are at risk of inflammatory bowel disease (IBD), with the risk varying by age, AD severity, and IBD subtype, according to a study.

Atopic dermatitis linked to subsequent IBD

05 Sep 2023

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Women who conceive following infertility treatment appear to have a higher likelihood of stroke-related hospitalization within 12 months of delivery as compared with those who spontaneously conceive, according to a study.

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

04 Sep 2023 by

Patients with atrial high-rate episodes (AHRE) do not seem to benefit from anticoagulation with edoxaban, which has fallen short of reducing the composite outcome of stroke, systemic embolism, or cardiovascular death, according to the results of the NOAH-AFNET* 6 trial.

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

04 Sep 2023

At which dose does cannabis become toxic to kids?

03 Sep 2023

Ingestion of tetrahydrocannabinol (THC) from edible cannabis at ≥1.7 mg/kg can lead to significant toxicity in young children, according to a study.

At which dose does cannabis become toxic to kids?

03 Sep 2023

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

01 Sep 2023 by

Monotherapy with recaticimab can significantly lower low-density lipoprotein cholesterol (LDL-C) levels in patients with nonfamilial hypercholesterolemia (non-FH) and mixed hyperlipidaemia, according to data from the phase III REMAIN-1 study presented at ESC 2023.

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

01 Sep 2023

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Treatment with brolucizumab results in a longer interval between injections of antivascular endothelial growth factor (anti-VEGF) agents for most treatment-experienced eyes, especially those with shorter intervals before switching, while maintaining or improving visual acuity (VA), reports a study.

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

News & Updates

Filter by Specialty:

Specialty:

Photobiomodulation works for chemo-induced peripheral neuropathy

Photobiomodulation works for chemo-induced peripheral neuropathy

Weight loss with high-dose oral semaglutide in obese nondiabetics

Weight loss with high-dose oral semaglutide in obese nondiabetics

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?

New COVID-19 variant puts scientists on alert

New COVID-19 variant puts scientists on alert

Atopic dermatitis linked to subsequent IBD

Atopic dermatitis linked to subsequent IBD

Infertility treatment carries increased risk of stroke hospitalization

Infertility treatment carries increased risk of stroke hospitalization

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

At which dose does cannabis become toxic to kids?

At which dose does cannabis become toxic to kids?

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients